3 ms·
Your 2nd reference talks about the theoretical lowest price that a hypothetical manufacturer could manufacture longer-acting insulins at. It doesn't identify an
by Scoundreller 7y ago
Your 2nd reference talks about the theoretical lowest price that a hypothetical manufacturer could manufacture longer-acting insulins at. It doesn't identify any manufacturer actually producing at those prices.
- rglover 7y agohttps://www.walmart.com/ip/Novolin-ReliOn-Insulin-N/167672445 https://www.walmart.com/ip/Novolin-ReliOn-Insulin-N/16767244...
- Thorrez 7y agoScoundreller wanted a manufacturer producing "the newer biosimilar insulin for just $72-133 per year". That link doesn't appear to provide that information.